Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis

Clinical trial NCT01486524 · UNKNOWN

Trial details

NCT number: NCT01486524
Sponsor: Sirius Genomics Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Severe Sepsis Septic Shock

Start date: 2011-10-01
Primary completion: 2012-04-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.